Propel Bio Management, LLC — 13F Holdings

2026 Q3  ·  34 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Propel Bio Management, LLC maintained a portfolio of 34 distinct positions. The most significant new addition was COLLEGIUM PHARMACEUTICAL, now representing 4.75% of the total fund value. They heavily accumulated shares in MAZE THERAPEUTICS INC, increasing the position by 338.4%. Conversely, Propel Bio Management, LLC completely exited their position in ZEVRA THERAPEUTICS INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
34
Quarter
2026 Q3
Top Holding
PAGP (17.5%)
Top 10 Concentration
68.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-34 of 34

Propel Bio Management, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
PAGP
PLAINS GP HOLDI...
Energy 17.47% 16.16% #1
Prev: #1
7.0
—
no change no change
P
S
1,272,360 $32,954,124
$12.83 +104.3%
$25.52 +2.7%
2023 Q4 13F Filing 2026-09-30 2026-11-13
ACHV
ACHIEVE LIFE SC...
Healthcare 16.57% 13.79% #2
Prev: #2
6.0
—
-169,870 -4.2%
P
S
3,864,148 $31,260,957 2024 Q1 13F Filing 2026-09-30 2026-11-13
DCTH
DELCATH SYSTEMS...
Healthcare 5.12% 5.74% #3 2
Prev: #5
3.0
—
-266,796 -30.6%
P
S
604,664 $9,656,484 2024 Q4 13F Filing 2026-09-30 2026-11-13
COLL
COLLEGIUM PHARM...
Healthcare 4.75% — #4
Prev: #—
5.9
—
410,175 —
NEW
410,175 $8,950,019 2026 Q3 13F Filing 2026-09-30 2026-11-13
CORT
CORCEPT THERAPE...
Healthcare 4.60% 6.21% #5 2
Prev: #3
2.3
—
-61,225 -44.9%
P
S
75,274 $8,673,823 2026 Q1 13F Filing 2026-09-30 2026-11-13
AQST
AQUESTIVE THERA...
Healthcare 4.56% 3.14% #6 5
Prev: #11
1.8
—
-1,163,674 -80.7%
P
S
278,723 $8,608,753 2026 Q1 13F Filing 2026-09-30 2026-11-13
MIST
MILESTONE PHARM...
Healthcare 4.34% 5.21% #7 1
Prev: #6
4.2
—
2,020,137 27.2%
P
S
9,449,727 $8,180,629 2025 Q1 13F Filing 2026-09-30 2026-11-13
PHAT
PHATHOM PHARMAC...
Healthcare 4.28% 5.96% #8 4
Prev: #4
3.7
—
55,555 5.3%
P
S
1,105,913 $8,073,165 2023 Q4 13F Filing 2026-09-30 2026-11-13
CMPS
COMPASS PATHWAY...
Healthcare 3.62% 4.24% #9 2
Prev: #7
1.9
—
-23,900 -4.2%
P
S
549,186 $6,831,874 2024 Q3 13F Filing 2026-09-30 2026-11-13
OBIO
ORCHESTRA BIOME...
Healthcare 2.96% 2.02% #10 6
Prev: #16
2.2
—
no change no change
P
S
896,701 $5,577,480 2026 Q1 13F Filing 2026-09-30 2026-11-13
MAZE
MAZE THERAPEUTI...
Healthcare 2.77% 0.68% #11 16
Prev: #27
4.1
—
148,200 338.4%
P
S
191,998 $5,218,506 2026 Q1 13F Filing 2026-09-30 2026-11-13
ABEO
ABEONA THERAPEU...
Healthcare 2.66% 3.18% #12 2
Prev: #10
1.6
—
-27,063 -2.8%
P
S
956,007 $5,019,037 2024 Q2 13F Filing 2026-09-30 2026-11-13
ARTV
ARTIVA BIOTHERA...
Healthcare 2.63% 3.54% #13 4
Prev: #9
2.1
—
no change no change
P
S
696,436 $4,958,624 2026 Q1 13F Filing 2026-09-30 2026-11-13
KYTX
KYVERNA THERAPE...
Healthcare 2.53% 4.12% #14 6
Prev: #8
1.0
—
-182,603 -20.7%
P
S
700,595 $4,764,046 2025 Q4 13F Filing 2026-09-30 2026-11-13
IVA
INVENTIVA SA - ...
Healthcare 2.22% 2.53% #15 1
Prev: #14
1.4
—
-147,258 -11.5%
P
S
1,133,954 $4,184,290 2025 Q4 13F Filing 2026-09-30 2026-11-13
CABA
CABALETTA BIO I...
Healthcare 2.09% — #16
Prev: #—
4.3
—
2,049,471 —
NEW
2,049,471 $3,934,984 2026 Q3 13F Filing 2026-09-30 2026-11-13
SABS
SAB BIOTHERAPEU...
Healthcare 2.00% 2.20% #17 2
Prev: #15
2.8
—
110,844 10.3%
P
S
1,187,422 $3,764,128 2025 Q4 13F Filing 2026-09-30 2026-11-13
PROK
PROKIDNEY CORP
Healthcare 1.77% — #18
Prev: #—
4.2
—
2,009,733 —
NEW
2,009,733 $3,336,157 2026 Q3 13F Filing 2026-09-30 2026-11-13
CRVS
CORVUS PHARMACE...
Healthcare 1.61% 0.55% #19 9
Prev: #28
3.6
—
193,930 275.5%
P
S
264,310 $3,044,851 2026 Q1 13F Filing 2026-09-30 2026-11-13
PALI
PALISADE BIO IN...
Healthcare 1.59% 2.82% #20 8
Prev: #12
1.1
—
-358,199 -13.9%
P
S
2,224,189 $3,002,655 2026 Q1 13F Filing 2026-09-30 2026-11-13
OCUL
OCULAR THERAPEU...
Healthcare 1.46% 1.84% #21 2
Prev: #19
1.6
—
no change no change
P
S
357,966 $2,745,599 2026 Q1 13F Filing 2026-09-30 2026-11-13
SCYX
SCYNEXIS INC
Healthcare 1.42% 1.16% #22 2
Prev: #24
1.1
—
-2,004 -0.4%
P
S
541,474 $2,674,882 2026 Q2 13F Filing 2026-09-30 2026-11-13
FDMT
4D MOLECULAR TH...
Healthcare 1.36% 1.76% #23 3
Prev: #20
0.5
—
-73,500 -29.1%
P
S
179,154 $2,563,694 2026 Q1 13F Filing 2026-09-30 2026-11-13
OVID
OVID THERAPEUTI...
Healthcare 1.34% 1.57% #24 3
Prev: #21
1.0
—
-96,817 -8.7%
P
S
1,018,721 $2,536,615 2026 Q1 13F Filing 2026-09-30 2026-11-13
IMUX
IMMUNIC INC
Healthcare 1.17% 2.61% #25 12
Prev: #13
0.5
—
-88,288 -27.2%
P
S
236,734 $2,201,626 2026 Q1 13F Filing 2026-09-30 2026-11-13
UPB
UPSTREAM BIO IN...
Healthcare 0.94% 1.27% #26 3
Prev: #23
0.9
—
-15,000 -4.3%
P
S
335,389 $1,767,500 2026 Q1 13F Filing 2026-09-30 2026-11-13
IRD
OPUS GENETICS I...
Healthcare 0.69% — #27
Prev: #—
3.8
—
270,036 —
NEW
270,036 $1,306,974 2026 Q3 13F Filing 2026-09-30 2026-11-13
CLDX
CELLDEX THERAPE...
Healthcare 0.65% 2.02% #28 11
Prev: #17
0.3
—
-66,156 -63.8%
P
S
37,539 $1,216,639 2025 Q3 13F Filing 2026-09-30 2026-11-13
N/A
SPYGLASS PHARMA...
Unknown 0.57% — #29
Prev: #—
3.7
—
41,418 —
NEW
41,418 $1,076,868 — 13F Filing 2026-09-30 2026-11-13
LONA
LEONABIO INC
Healthcare 0.28% 0.72% #30 4
Prev: #26
1.1
—
no change no change
P
S
149,279 $532,926 2025 Q3 13F Filing 2026-09-30 2026-11-13
SGMT
SAGIMET BIOSCIE...
Healthcare 0.00% 0.51%
Sold All 😨
(Was: #29)
0.0
—
-125,878 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
SLN
SILENCE THERAPE...
Healthcare 0.00% 1.10%
Sold All 😨
(Was: #25)
0.0
—
-191,733 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
EYPT
EYEPOINT INC
Healthcare 0.00% 1.43%
Sold All 😨
(Was: #22)
0.0
—
-191,745 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
ZVRA
ZEVRA THERAPEUT...
Healthcare 0.00% 1.90%
Sold All 😨
(Was: #18)
0.0
—
-253,544 -100.0%
CLOSED
— $— 2024 Q3 13F Filing 2026-09-30 2026-11-13
Showing 1-34 of 34 holdings

Unlock Full Propel Bio Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →